查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390539

中風管理市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球卒中管理市場規模達到334億美元。展望未來， IMARC Group預計到2028年市場規模將達到500億美元，2022-2028年複合年成長率（CAGR）為6.96%。中風對醫療保健系統造成的負擔不斷增加，對以患者為中心的護理和個性化治療計劃的日益關注，以及為改善中風管理技術和開發新療法而不斷加大的研發力度，是推動市場發展的一些因素。

中風管理涉及一種綜合方法來減少中風的影響和長期後果，中風是一種由大腦血流中斷引起的醫療緊急情況。有效的中風管理對於最大限度地減少腦損傷、改善患者的治療效果和提高生活品質至關重要。及時、準確的診斷對於中風治療至關重要。快速評估工具，例如 FAST 縮寫（臉部下垂、手臂無力、言語困難、呼叫緊急服務時間），有助於識別中風症狀並及時進行醫療干預。診斷影像，例如電腦斷層掃描 (CT) 掃描或磁振造影 (MRI)，有助於確定中風的類型和位置。立即治療的重點是恢復大腦的血液流動。組織纖溶酶原活化劑 (tPA) 或機械血栓切除術等溶栓藥物可用於治療缺血性中風。出血性中風可能需要手術干預來止血並緩解大腦壓力。中風後管理涉及復健以恢復喪失的功能並預防殘疾。這可能包括物理治療、職業治療、語言治療和心理支持。也可能會開立治療高血壓、高膽固醇和血液稀釋劑等危險因子的藥物。此外，預防措施對於降低中風復發的風險至關重要。生活方式的改變，例如健康飲食、定期運動、戒菸以及管理糖尿病或心房顫動等慢性疾病，對於中風管理至關重要。中風治療和復健領域的持續研究和進步不斷改善中風管理策略和結果。

全球市場主要是由中風發病率不斷上升所推動的。與此一致的是，人口老化的加劇對市場做出了重大貢獻。此外，診斷、影像和治療選擇方面不斷進步的技術正在對市場產生積極影響。大眾對中風症狀和及時治療重要性的認知不斷提高，也刺激了市場。此外，政府針對中風預防和管理的運動和措施促進了市場擴張。此外，中風管理程序和治療的優惠報銷政策激勵了醫療保健提供者並推動了市場。此外，遠距醫療和遠端監控技術的快速採用可以實現遠端中風管理並擴大市場範圍。專門的中風中心和專業設施的建立增強了中風管理能力並增強了市場。

中風管理市場趨勢/促進因素：

慢性病盛行率增加

慢性病盛行率的上升正在培育市場。心血管疾病、糖尿病和高血壓等慢性疾病是主要的中風危險因子。隨著全球人口老化和生活方式變得更加久坐，這些慢性病的盛行率持續增加。這導致更多的人面臨中風的風險。慢性病盛行率的不斷上升對有效的中風管理策略提出了更大的需求。敦促醫療保健提供者和組織制定全面的中風預防計劃並實施及時有效的治療方案。此外，越來越需要對慢性病進行持續監測和管理，以盡量減少中風發生或復發的風險。正在實施公共衛生措施、教育活動和預防措施，以提高人們對慢性病和中風之間關係的認知。這些努力旨在促進早期發現、生活方式改變和堅持治療方案，最終減輕中風負擔並推動中風管理解決方案市場的發展。

個人對早期診斷和治療益處的認知不斷提高

人們對早期診斷和治療的好處的認知不斷提高，為市場創造了積極的前景。隨著大眾對中風徵兆、症狀和後果的了解不斷加深，人們越來越主動地尋求及時的醫療協助。意識的提高使個人能夠及時識別中風症狀並了解立即尋求醫療協助的重要性。識別出突然的麻木或虛弱、說話或理解困難以及嚴重頭痛等症狀會促使個人立即尋求緊急護理。早期診斷和及時治療對於最大限度地減少中風的影響和改善患者的預後至關重要。隨著意識的增強，個人更有可能迅​​速採取行動，從而更快地進行干預和可能挽救生命的治療，例如溶栓藥物或機械血栓切除術。提高意識的努力包括公共衛生運動、教育措施和社區外展計劃。這些努力旨在教育個人有關中風預防、危險因素以及立即醫療干預的必要性。透過提高意識，個人能夠採取積極主動的措施，提振中風管理解決方案市場並改善整體中風護理。

引進新的先進設備和藥物

引進新的先進設備和藥物為市場提供了許多機會。醫療設備和藥品的技術進步和持續創新徹底改變了中風護理，改善了患者的治療效果並促進了市場發展。先進影像、神經介入和機器人輔助系統等新設備提高了中風診斷和治療的準確性和精確度。這些設備使醫療保健提供者能夠快速有效地清除血栓，恢復大腦的血液流動，並最大限度地減少腦損傷的程度。此外，創新的復健設備和輔助技術有助於中風恢復和復原。新藥和藥物干預措施的發展也對推動市場發揮了至關重要的作用。溶栓藥物、神經保護藥物和抗血小板藥物顯著改善了中風的治療和預防。這些藥物旨在溶解血栓、保護腦細胞並控制危險因素，以降低中風復發的可能性。此外，新設備和藥物的引入導致中風管理發生範式轉變，實現更精確的診斷、微創治療和標靶治療。這些進步增強了患者護理，並為醫療保健提供者和製造商創造了新的機會，推動了市場的發展。

中風管理產業細分：

IMARC Group提供了全球卒中管理市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據類型、應用程式和最終用戶對市場進行了分類。

按類型分類：

診斷

電腦斷層掃描（CT 掃描）

磁振造影 (MRI)

頸動脈超音波檢查

腦血管攝影

心電圖

超音波心臟檢查

其他

療法

組織纖溶酶原活化劑

抗凝血劑

抗血小板藥

抗高血壓

診斷主導市場

該報告根據類型提供了詳細的市場細分和分析。這包括診斷（電腦斷層掃描（CT 掃描）、磁振造影（MRI）、頸動脈超音波、腦血管攝影、心電圖、超音波心動圖等）和治療（組織纖溶酶原活化劑、抗凝血劑、抗血小板劑和抗高血壓劑）。根據該報告，診斷佔據了最大的部分。

診斷對於準確識別和評估中風、做出及時有效的治療決策至關重要。 CT 掃描和 MRI 是用於評估中風患者的關鍵診斷工具。 CT 掃描提供快速影像來檢測血管出血或阻塞，幫助確定中風的類型和位置。另一方面，核磁共振成像可提供詳細的腦部影像，有助於識別缺血區域並制定治療計劃。中風盛行率的增加以及對早期檢測和介入的重視推動了對 CT 掃描和 MRI 等診斷工具的需求。

CT 和 MRI 影像的技術進步，例如更高的解析度、更快的掃描時間和改進的影像協議，提高了中風診斷的準確性和效率。將人工智慧 (AI) 演算法整合到成像系統中，實現成像資料的自動分析和解釋，進一步推動了診斷領域的成長。這簡化了診斷過程，加快了治療決策，並改善了患者的治療效果。

按應用分類：

缺血性中風

出血性中風

其他

缺血性中風佔最大市場佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括缺血性中風、出血性中風等。報告顯示，缺血性中風佔了最大的市場佔有率。

缺血性中風是最常見的類型，由供應大腦的血管阻塞或狹窄引起，導致血流量和氧氣輸送減少。對缺血性中風治療的關注推動了市場的成長，因為它佔中風病例的很大一部分。缺血性中風的發生率不斷增加，通常與高血壓、糖尿病和久坐生活方式等危險因子有關，需要有效的管理策略。

缺血性中風治療的進步，例如組織纖溶酶原活化劑 (tPA) 等溶栓藥物的開發和機械血栓切除術，徹底改變了治療選擇。這些干預措施旨在恢復受影響區域的血流，最大限度地減少腦損傷並改善患者的治療結果。促進中風預防、早期識別症狀和快速介入的公共衛生措施進一步支持了對缺血性中風管理的重視。這些措施透過提高意識、鼓勵個人及時尋求醫療協助以及實施實證管理方法來推動市場發展。

按最終用戶分類：

醫院

門診手術中心

診斷中心

其他

醫院佔最大市場佔有率

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院、門診手術中心、診斷中心等。報告顯示，醫院佔據了最大的市場。

醫院在中風治療中發揮著至關重要的作用，因為它們是急性中風治療、專業診斷和復健服務的主要醫療機構。醫院需要為患者提供全面和專業的中風護理，這推動了對中風管理解決方案的需求。隨著中風負擔的增加，醫院努力提高中風診斷、治療和復原的能力，對市場產生正面影響。

醫院投資先進的影像系統、神經介入設備和復健技術，以提供最佳的中風護理。他們與中風管理公司合作並參與臨床研究，以實施實證實踐並提供最新的治療方案。此外，醫院還充當中風教育和培訓中心，向醫療保健專業人員傳播有關中風預防、早期識別和適當管理的知識。這有助於改善患者的治療效果並提高醫療保健界的認知，從而推動市場發展。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位，佔據最大的市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。

由於多種因素促進其成長和發展，北美是卒中管理的關鍵市場。該地區中風發病率很高，使其成為中風管理解決方案的重要市場。該地區人口老化、久坐的生活方式以及高血壓和肥胖等危險因子的高發生率導致中風負擔增加。此外，該地區擁有先進的醫療基礎設施和強大的研發能力。這使得該地區能夠在開發和採用創新的中風管理技術、診斷工具和治療方式方面處於領先地位。

此外，北美擁有完善的醫療保健系統和報銷結構，支援中風管理解決方案的採用。中風相關干預和治療的優惠報銷政策和保險範圍推動了市場的發展。北美領先的中風管理公司、醫療保健提供者和研究機構的存在促進了中風管理實踐的合作、研究和進步。這透過不斷改善治療效果並推動新技術和工藝的採用來促進市場成長。

競爭格局：

頂級中風管理公司正在透過其專業知識、創新和對改善患者治療結果的承諾來加強市場。這些公司在研發方面投入巨資，開發尖端技術、設備和藥品，以有效預防、診斷、治療和復健中風。領先的中風管理公司積極與醫療保健提供者、研究機構和行業專家合作，推動創新並保持在中風護理領域的前沿。他們進行臨床試驗和研究以收集循證資料並不斷改進其產品和服務。這些公司對於提高中風預防和早期介入的認知也至關重要。他們參與教育活動、公共衛生運動以及與患者倡導團體的合作，以提高中風意識並為醫療保健專業人員和公眾提供資源。此外，頂級中風管理公司專注於提供涵蓋診斷、急性護理、復健和持續管理的全面解決方案。透過提供以患者為中心的綜合方法，他們致力於推動中風管理實踐，努力最佳化患者治療結果並提高生活品質。

該報告對中風管理市場的競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

雅培實驗室

貝朗梅爾松根股份公司

波士頓科學公司

百時美施貴寶公司

康德樂

通用電氣公司

葛蘭素史克公司

美敦力公司

默克公司

西門子醫療保健公司（Siemens AG）。

最近的發展：

2019 年，雅培推出了 Alinity m 診斷系統，這是一個緊湊的分子檢測平台，旨在為 HIV、肝炎等傳染病提供快速、準確的結果。

2019 年，貝朗宣布與 GuardRFID Solutions 合作，增強公司的資產追蹤和管理能力，並提高醫療保健環境的效率。

2019 年，波士頓科學公司的 WATCHMAN FLX 左心耳封堵器 (LAAC) 裝置獲得 FDA 批准，這是一種微創植入裝置，用於降低非瓣膜性心房顫動患者中風的風險。

本報告回答的關鍵問題：

  • 迄今為止，全球卒中管理市場表現如何，未來幾年將如何表現？
  • 全球卒中管理市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球卒中管理市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的中風管理市場？
  • 依類型分類市場是怎麼樣的？
  • 全球卒中管理市場中哪種類型最具吸引力？
  • 基於應用程式的市場區隔是什麼？
  • 全球卒中管理市場中最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 全球中風管理市場中哪一個是最具吸引力的最終用戶？
  • 全球卒中管理市場的競爭結構如何？
  • 全球中風管理市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球卒中管理市場表現如何，未來幾年將如何表現？
  • 全球卒中管理市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球卒中管理市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的中風管理市場？
  • 依類型分類市場是怎麼樣的？
  • 全球卒中管理市場中哪種類型最具吸引力？
  • 基於應用程式的市場區隔是什麼？
  • 全球卒中管理市場中最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 全球中風管理市場中哪一個是最具吸引力的最終用戶？
  • 全球卒中管理市場的競爭結構如何？
  • 全球中風管理市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球中風管理市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按類型分類的市場細分

  • 診斷
    • 市場走向
    • 關鍵環節
      • 電腦斷層掃描（CT 掃描）
      • 磁振造影 (MRI)
      • 頸動脈超音波檢查
      • 腦血管攝影
      • 心電圖
      • 超音波心臟檢查
      • 其他
    • 市場預測
  • 療法
    • 市場走向
    • 關鍵環節
      • 組織纖溶酶原活化劑
      • 抗凝血劑
      • 抗血小板藥
      • 抗高血壓
    • 市場預測

第 7 章：按應用分類的市場區隔

  • 缺血性中風
    • 市場走向
    • 市場預測
  • 出血性中風
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 診斷中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • Bristol-Myers Squibb Company
    • Cardinal Health
    • General Electric Company
    • GlaxoSmithKline plc
    • Medtronic plc
    • Merck & Co. Inc.
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112023A4313

Abstract

The global stroke management market size reached US$ 33.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 50.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.96% during 2022-2028. The rising burden of strokes on healthcare systems, the increasing focus on patient-centered care and personalized treatment plans, and the growing research and development efforts to improve stroke management techniques and develop new therapies are some of the factors propelling the market.

Stroke management involves a comprehensive approach to reduce the impact and long-term consequences of stroke, a medical emergency caused by disrupted blood flow to the brain. Effective stroke management is crucial to minimize brain damage, improve patient outcomes, and enhance quality of life. Prompt and accurate diagnosis is essential in stroke management. Quick assessment tools, such as the FAST acronym (Facial drooping, Arm weakness, Speech difficulties, Time to call emergency services), aid in identifying stroke symptoms and enabling timely medical intervention. Diagnostic imaging, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), helps determine the type and location of the stroke. Immediate treatment focuses on restoring blood flow to the brain. Clot-dissolving medications like tissue plasminogen activator (tPA) or mechanical thrombectomy may be used for ischemic stroke. Hemorrhagic stroke may require surgical interventions to stop bleeding and relieve pressure on the brain. Post-stroke management involves rehabilitation to restore lost functions and prevent disability. This may include physical therapy, occupational therapy, speech therapy, and psychological support. Medications to manage risk factors like high blood pressure, high cholesterol, and blood thinners may also be prescribed. Additionally, preventive measures are essential to reduce the risk of recurrent strokes. Lifestyle modifications such as a healthy diet, regular exercise, smoking cessation, and managing chronic conditions, such as diabetes or atrial fibrillation, are crucial to stroke management. Ongoing research and advancements in stroke treatment and rehabilitation continue to improve stroke management strategies and outcomes.

The global market is primarily driven by the growing incidence of strokes. In line with this, the increasing aging population is significantly contributing to the market. Furthermore, the rising technological advancements in diagnostics, imaging, and treatment options are positively influencing the market. The growing public awareness about the signs, symptoms, and importance of prompt stroke management is also catalyzing the market. Moreover, the government's campaigns and initiatives to address stroke prevention and management promote market expansion. Besides, the favorable reimbursement policies for stroke management procedures and treatments incentivize healthcare providers and propel the market. Additionally, the rapid adoption of telemedicine and remote monitoring technologies allows for remote stroke management and expands the market reach. The establishment of dedicated stroke centers and specialized facilities enhances stroke management capabilities and strengthens the market.

Stroke Management Market Trends/Drivers:

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases is fostering the market. Chronic diseases, such as cardiovascular diseases, diabetes, and hypertension, are major stroke risk factors. As the global population ages and lifestyles become more sedentary, the prevalence of these chronic conditions continues to increase. This results in a larger population at risk of experiencing strokes. The increasing prevalence of chronic diseases creates a greater demand for effective stroke management strategies. Healthcare providers and organizations are prompted to develop comprehensive stroke prevention programs and implement timely and efficient treatment protocols. Additionally, there is a growing need for ongoing monitoring and management of chronic conditions to minimize the risk of stroke occurrence or recurrence. Public health initiatives, education campaigns, and preventive measures are being implemented to raise awareness about the relationship between chronic diseases and strokes. These efforts aim to promote early detection, lifestyle modifications, and adherence to treatment regimens, ultimately reducing the burden of strokes and fueling the market for stroke management solutions.

Rising awareness among individuals regarding the benefits of early diagnosis and treatments

Rising awareness among individuals about the benefits of early diagnosis and treatments is creating a positive outlook for the market. As public knowledge about the signs, symptoms, and consequences of strokes improves, individuals are becoming more proactive in seeking timely medical attention. Increased awareness empowers individuals to recognize stroke symptoms promptly and understand the importance of seeking immediate medical help. Recognizing symptoms such as sudden numbness or weakness, difficulty speaking or understanding, and severe headache prompts individuals to seek emergency care without delay. Early diagnosis and prompt treatment are critical in minimizing the impact of strokes and improving patient outcomes. With greater awareness, individuals are more likely to act swiftly, leading to faster intervention and potentially life-saving treatments such as clot-dissolving medications or mechanical thrombectomy. Efforts to raise awareness include public health campaigns, educational initiatives, and community outreach programs. These endeavors aim to educate individuals about stroke prevention, risk factors, and the need for immediate medical intervention. By increasing awareness, individuals are empowered to take proactive measures, bolstering the market for stroke management solutions and improving overall stroke care.

Introduction of new and advanced devices and drugs

Introducing new and advanced devices and drugs offers numerous opportunities for the market. Technological advancements and continuous innovation in medical devices and pharmaceuticals have revolutionized stroke care, improving patient outcomes and catalyzing the market. New devices, such as advanced imaging, neuro-interventional, and robotic-assisted systems, have enhanced the accuracy and precision of stroke diagnosis and treatment. These devices enable healthcare providers to swiftly and effectively remove clots, restore blood flow to the brain, and minimize the extent of brain damage. Additionally, innovative rehabilitation devices and assistive technologies aid in stroke recovery and rehabilitation. The development of new drugs and pharmaceutical interventions has also played a vital role in driving the market. Thrombolytic drugs, neuroprotective agents, and antiplatelet medications have significantly improved stroke treatment and prevention. These drugs aim to dissolve clots, protect brain cells, and manage risk factors to reduce the likelihood of recurrent strokes. Moreover, introducing new devices and drugs has led to a paradigm shift in stroke management, enabling more precise diagnoses, minimally invasive treatments, and targeted therapies. These advancements enhance patient care and create new opportunities for healthcare providers and manufacturers, propelling the market.

Stroke Management Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global stroke management market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Diagnostics

Computed Tomography Scan (CT Scan)

Magnetic Resonance Imaging (MRI)

Carotid Ultrasound

Cerebral Angiography

Electrocardiography

Echocardiography

Others

Therapeutics

Tissue Plasminogen Activator

Anticoagulant

Antiplatelet

Antihypertensive

Diagnostics dominate the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes diagnostics (computed tomography scan (CT Scan), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, others) and therapeutics (tissue plasminogen activator, anticoagulant, antiplatelet, and antihypertensive). According to the report, diagnostics represented the largest segment.

Diagnostics are crucial in accurately identifying and assessing strokes, enabling timely and effective treatment decisions. CT scans and MRIs are key diagnostic tools used to evaluate stroke patients. CT scans provide rapid imaging to detect bleeding or blockages in blood vessels, helping determine the type and location of the stroke. MRIs, on the other hand, offer detailed brain imaging, assisting in identifying ischemic areas and aiding in treatment planning. The increasing prevalence of strokes and the emphasis on early detection and intervention drive the demand for diagnostic tools, such as CT scans and MRIs.

Technological advancements in CT and MRI imaging, such as higher resolution, faster scanning times, and improved imaging protocols, have enhanced the accuracy and efficiency of stroke diagnosis. The diagnostics segment's growth is further fuelled by integrating artificial intelligence (AI) algorithms into imaging systems, enabling automated analysis and interpretation of imaging data. This streamlines the diagnostic process, expedites treatment decisions, and improves patient outcomes.

Breakup by Application:

Ischemic Stroke

Haemorrhagic Stroke

Others

Ischemic Stroke holds the largest share of the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes ischemic stroke, haemorrhagic stroke, and others. According to the report, ischemic stroke accounted for the largest market share.

Ischemic stroke is the most common type, caused by the blockage or narrowing of blood vessels supplying the brain, leading to reduced blood flow and oxygen delivery. The focus on ischemic stroke management drives themarket growth as it accounts for a substantial portion of stroke cases. The increasing incidence of ischemic stroke, often associated with risk factors like hypertension, diabetes, and a sedentary lifestyle, demands effective management strategies.

Advancements in ischemic stroke management, such as the development of thrombolytic drugs like tissue plasminogen activator (tPA) and mechanical thrombectomy procedures, have revolutionized treatment options. These interventions aim to restore blood flow to the affected area, minimize brain damage, and improve patient outcomes. The emphasis on ischemic stroke management is further supported by public health initiatives promoting stroke prevention, early recognition of symptoms, and rapid intervention. These initiatives propel the market by increasing awareness, encouraging individuals to seek medical help promptly, and implementing evidence-based management approaches.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Others

Hospitals holds the largest share of the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, ambulatory surgical centers, diagnostic centers, and others. According to the report, hospitals accounted for the largest market share.

Hospitals play a critical role in stroke care, as they are the primary healthcare facilities for acute stroke treatment, specialized diagnostics, and rehabilitation services. The demand for stroke management solutions is propelled by hospitals' need to provide patients with comprehensive and specialized stroke care. As the burden of strokes rises, hospitals strive to enhance their capabilities in stroke diagnosis, treatment, and rehabilitation, impacting the market positively.

Hospitals invest in advanced imaging systems, neuro-interventional devices, and rehabilitation technologies to deliver optimal stroke care. They collaborate with stroke management companies and engage in clinical research to implement evidence-based practices and offer the latest treatment options. Furthermore, hospitals serve as centers for stroke education and training, disseminating knowledge to healthcare professionals regarding stroke prevention, early recognition, and appropriate management. This contributes to improved patient outcomes and raises awareness among the healthcare community, propelling the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

North America is a key market for stroke management due to several factors contributing to its growth and development. The region has a high prevalence of stroke cases, making it a significant market for stroke management solutions. The region's aging population, sedentary lifestyles, and high incidence of risk factors such as hypertension and obesity contribute to the increased burden of strokes. Furthermore, the region boasts advanced healthcare infrastructure and robust research and development capabilities. This enables the region to lead in developing and adopting innovative stroke management technologies, diagnostic tools, and treatment modalities.

Moreover, North America has a well-established healthcare system and reimbursement structure that supports the adoption of stroke management solutions. Favorable reimbursement policies and insurance coverage for stroke-related interventions and treatments drive the market. The presence of leading stroke management companies, healthcare providers, and research institutions in North America fosters collaboration, research, and advancements in stroke management practices. This contributes to the market growth by continually improving treatment outcomes and driving the adoption of new technologies and techniques.

Competitive Landscape:

Top stroke management companies are strengthening the market through their expertise, innovation, and commitment to improving patient outcomes. These companies invest heavily in research and development to develop cutting-edge technologies, devices, and pharmaceuticals for effective stroke prevention, diagnosis, treatment, and rehabilitation. Leading stroke management companies actively collaborate with healthcare providers, research institutions, and industry experts to drive innovation and stay at the forefront of stroke care. They conduct clinical trials and studies to gather evidence-based data and continuously improve their products and services. These companies are also crucial in raising awareness about stroke prevention and early intervention. They engage in educational initiatives, public health campaigns, and partnerships with patient advocacy groups to promote stroke awareness and provide resources to healthcare professionals and the general public. Moreover, top stroke management companies focus on delivering comprehensive solutions that encompass diagnostics, acute care, rehabilitation, and ongoing management. By offering integrated and patient-centric approaches, they strive to optimize patient outcomes and improve quality of life through their commitment to advancing stroke management practices.

The report has provided a comprehensive analysis of the competitive landscape in the stroke management market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

B. Braun Melsungen AG

Boston Scientific Corporation

Bristol-Myers Squibb Company

Cardinal Health

General Electric Company

GlaxoSmithKline plc

Medtronic plc

Merck & Co. Inc.

Siemens Healthineers AG (Siemens AG).

Recent Developments:

In 2019, Abbott launched the Alinity m diagnostics system, a compact molecular testing platform designed to deliver fast and accurate results for infectious diseases like HIV, hepatitis, and more.

In 2019, B. Braun announced a collaboration with GuardRFID Solutions to enhance the company's asset tracking and management capabilities, improving efficiency in healthcare environments.

In 2019, Boston Scientific received FDA approval for the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device, a minimally invasive implantable device for reducing the risk of stroke in patients with non-valvular atrial fibrillation.

Key Questions Answered in This Report:

  • How has the global stroke management market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global stroke management market?
  • What is the impact of each driver, restraint, and opportunity on the global stroke management market?
  • What are the key regional markets?
  • Which countries represent the most attractive stroke management market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the global stroke management market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the global stroke management market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global stroke management market?
  • What is the competitive structure of the global stroke management market?
  • Who are the key players/companies in the global stroke management market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stroke Management Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Computed Tomography Scan (CT Scan)
      • 6.1.2.2 Magnetic Resonance Imaging (MRI)
      • 6.1.2.3 Carotid Ultrasound
      • 6.1.2.4 Cerebral Angiography
      • 6.1.2.5 Electrocardiography
      • 6.1.2.6 Echocardiography
      • 6.1.2.7 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Tissue Plasminogen Activator
      • 6.2.2.2 Anticoagulant
      • 6.2.2.3 Antiplatelet
      • 6.2.2.4 Antihypertensive
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Ischemic Stroke
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Haemorrhagic Stroke
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cardinal Health
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 GlaxoSmithKline plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Merck & Co. Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens Healthineers AG (Siemens AG)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Stroke Management Market: Major Drivers and Challenges
  • Figure 2: Global: Stroke Management Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Stroke Management Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Stroke Management Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Stroke Management Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Stroke Management Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Stroke Management Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Stroke Management (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Stroke Management (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Stroke Management (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Stroke Management (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Stroke Management (Ischemic Stroke) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Stroke Management (Ischemic Stroke) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Stroke Management (Haemorrhagic Stroke) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Stroke Management (Haemorrhagic Stroke) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Stroke Management (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Stroke Management (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Stroke Management (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Stroke Management (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Stroke Management (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Stroke Management (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Stroke Management (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Stroke Management (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Stroke Management (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Stroke Management (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Stroke Management Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Stroke Management Industry: SWOT Analysis
  • Figure 76: Global: Stroke Management Industry: Value Chain Analysis
  • Figure 77: Global: Stroke Management Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Stroke Management Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Stroke Management Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Stroke Management Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Stroke Management Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Stroke Management Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Stroke Management Market: Competitive Structure
  • Table 7: Global: Stroke Management Market: Key Players